Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MUMS designation for Panion's gene therapy takes it to forefront of innovation in pet epilepsy

Whilst gene editing is not a new arena, Panion Animal Health is taking treatments in this space in a new direction. Following a minor use minor species designation from the US FDA, Animal Pharm analyst Sian Lazell spoke to chief executive Anja Holm about the mechanics behind the firm's therapy for targeting epilepsy in pets. 

Advertisement

What to read next

Advertisement
UsernamePublicRestriction

Register

AP013025

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel